Pharmacokinetic/Pharmacodynamic Equivalence of MSB11455 in Healthy Subjects

NCT03251248 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

294

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: MSB11455
DRUG: Neulasta

Sponsor

Fresenius Kabi SwissBioSim GmbH